Αποτελέσματα Αναζήτησης
16 Απρ 2020 · These evidence-based guidelines of the American Society of Hematology are intended to support the SCD community in decisions about prevention, diagnosis, and treatment of the most common neurological morbidities in SCD.
27 Ιαν 2020 · Guidance for specific indications and administration of transfusion, as well as screening, prevention, and management of alloimmunization, delayed hemolytic transfusion reactions (DHTRs), and iron overload may improve outcomes.
• Management of a sickle cell acute painful crisis is supportive with pain relief. All cases must be discussed with the Haematologist on call. • Principles of initial assessment and investigation (as per page 5 of the guideline) and supportive measures (as per page 6 of the guideline) should be followed. In addition: 2.8. Analgesia
19 Ιουν 2020 · These evidence-based guidelines developed by the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in pain management decisions for children and adults with SCD.
Acute vaso-occlusive episodes (VOE), also known as vaso-occlusive crises, or painful sickle crises, are caused by blockage of capillaries by sickled cells, with subsequent tissue infarction. In SCD, the usually flexible biconcave red blood cells can become rigid and ‘sticky’ as a result of polymerisation of sickle haemoglobin.
• Evidence-based treatment guidelines for sickle cell disease complications that affect the heart, lungs, and kidneys. • SCD affects multiple organs that require patients to seek care from doctors that
25 Φεβ 2024 · Implement evidence-based treatment and management options available for sickle cell crisis. Develop interprofessional team strategies for improving care coordination to manage sickle cell crises and improve outcomes. Access free multiple choice questions on this topic.
